baber/WOPTO huggingface dataset:
Patent IL-88848-A0 (IL)
Title: Immunoassays utilizing chemiluminescent esters,thioesters and amides as the labels
IPC: C07D263/10
Filed: 1988-12-30
Abstract: In accordance with the present invention, specific binding assays are disclosed which utilize an chemiluminescent compound, i.e., moiety, which has increased stability in aqueous solution. The chemiluminescent moiety is an ester, thioester or amide in which the ester, thioester or amide linkage is between (1) a heterocyclic ring or ring system containing a carbon atom to which the linkage is attached, wherein the heteroatom within the heterocyclic ring or ring system is in an oxidation state which renders such carbon atom susceptible to attack by peroxide or molecular oxygen to form an intermediate which decays to produce chemiluminescence, and (2) an aryl ring or ring system. The aryl ring or ring system contains at least one substituted six-member ring. The substituted six-member ring has two or more substituent groups, where at least two of said two or more substituent groups sterically hinder hydrolysis of said linkage. One or more of the substituent groups which sterically hinder hydrolysis of said linkage may be an electron withdrawing group. The substituted six-member ring may have one or more additional substituent groups in addition to the substituent groups which sterically hinder hydrolysis of the linkage. Such additional substituent groups may also be an electron withdrawing group. The carbon atom in the heterocyclic ring or ring system, to which the linkage is attached, may also have a secondary substituent of the formula RnX-, where X is selected from the group consisting of O, N, S and C, where R is any group, and where n is a number such that X has proper valency. Other chemiluminescent moieties are disclosed which are characterized by a heterocyclic ring or ring system and a secondary substituent of the formula RnX-, with the ester, thioester or amide linkage being between the heterocyclic ring or ring system and a leaving group. The disclosed chemiluminescent moieties can also include substituents at peri positions within the heterocyclic ring or ring system. Also in accordance with the present invention, compositions including and assay kits incorporating such chemiluminescent moieties are disclosed.
Patent IL-94269-A0 (IL)
Title: Blind riveting member
IPC: F16B5/04
Filed: 1990-05-02
Abstract: The invention relates to a blind riveting member of the type comprising a tubular sleeve (1) and a mandrel (2) passing through said sleeve. The stem portion (5) of the tubular sleeve (1) comprises successively along its length, a first articulation zone (5a), an inclined portion (5b), a second articulation zone (5c) and an end portion (5d). These zones or portions are arranged in such a manner that the sleeve is subjected to a double folding during setting of the rivet which causes the inclined portion to expand and fold back upon itself toward the materials being assembled, forming a continuous rest surface at the periphery of the hole which contains the riveting member. The invention is applied in particular for assembling fragile materials such as composite materials. It permits providing a good vibration resistant holding for these materials without risk of damaging the same.
Patent AU-PR750501-A0 (AU)
Title: Products comprising quantum of bioparticles and method for production thereof
IPC: G01N33/48
Filed: 2001-09-05
Abstract: A method for forming a substantially solid product containing a desired quantum of bioparticle, the method comprising (a) providing a sample of bioparticle in liquid form; (b) selecting a desired quantum of the bioparticle; and (c) forming a substantially solid product containing the desired quantum of the bioparticle, wherein the product is capable of being transferred between containers in its solid form without loss of bioparticle, and wherein the product is capable of releasing the bioparticle in a liquid.
Patent FI-20012319-A0 (FI)
Inventor: KEMPPAINEN JUHA
IPC: H04L69/40
Filed: 2001-11-27
Abstract: A radio channel simulator configured to read radio channel data describing a radio channel and user data including at least one user signal, and to simulate the radio channel using a FIR filter comprising one or more FIR blocks for filtering the user data read based on radio channel data in connection with the simulation. The radio channel simulator is configured to transfer at least one FIR block at a delay level depicting a radio channel delay during simulation.
Patent IL-101925-A0 (IL)
Title: Inhibitors of cathepsin g and elastase for preventing connective tissue degradation
IPC: C07K5/06
Filed: 1992-05-19
Abstract: Novel compounds which are chemically linked inhibitors of the proteases Elastase and Cathepsin G prevent connective tissue degradation associated with neutrophil induced inflammatory disease.
Patent IL-103109-A0 (IL)
Title: Process for the preparation of a cephalosporin antibiotic
IPC: C07D501/04
Filed: 1992-09-08
Abstract: The present invention provides an anhydrous acylation process for the preparation of antibiotic, cefepime dihydrochloride hydrate which is substantially free of the anti-isomer and the  DELTA <2> isomer comprising the N-acylation of a silylated derivative of 7-amino-3-[(1-methyl-1-pyrrolidinio)-methyl]ceph-3-em-4-carboxylate with the syn-isomer of 2-(2-aminothiazol-4-yl)-2-methoxyimino acetyl chloride hydrochloride.
Patent IL-105376-A0 (IL)
Title: Pressure-sensitive adhesives
IPC: C08F8/30
Filed: 1993-04-14
Abstract: A pressure-sensitive adhesive having improved shear strength obtained by virtue of the formation of the enamine of a pendant acetoacetate is described. These materials contain acetoacetate functional monomer in a low Tg emulsion polymer. Shear strength is improved without compromise of either peel strength or tack.
Patent IL-105986-A0 (IL)
Title: Pharmaceutical compositions containing triazine compounds
IPC: A61K31/53
Filed: 1993-06-11
Abstract: PCT No. PCT/GB93/01243 Sec. 371 Date Dec. 6, 1994 Sec. 102(e) Date Dec. 6, 1994 PCT Filed Jun. 11, 1993 PCT Pub. No. WO93/25207 PCT Pub. Date Dec. 23, 19933,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine and its pharmaceutically and veterinarily acceptable salts have activity in (a) preventing or reducing dependence on, and (b) preventing or reducing tolerance or reverse tolerance to, a dependence inducing agent such as an opioid, a central nervous system depressant, a psychostimulant or nicotine.
Patent IL-108635-A0 (IL)
Title: Catalyst for use in an oxidation reaction
IPC: B01J23/52
Filed: 1994-02-14
Abstract: A catalyst for use in an oxidation reaction comprises a porous alumina support having captured thereon a complex comprising gold, a transition metal selected from cobalt and manganese, and the alumina, the concentration of gold on the support being less than 2 percent by mass of the catalyst, and the atomic ratio of gold to transition metal being in the range 1:30 to 1:200. The oxidation reaction may be the oxidation of carbon monoxide or a hydrocarbon.
Patent IL-111804-A0 (IL)
Title: Pharmaceutical compositions comprising dimeticone for the treatment of constipation
IPC: A61K31/80
Filed: 1994-11-29
Abstract: The invention disclosed relates to the use of dimeticone as an agent for treating constipation.
Patent IL-130987-A0 (IL)
Title: Unsymmetrical polyurea-urethane fertilizer encapsulation
IPC: C09D175/00
Filed: 1999-07-20
Abstract: This invention relates to processes for the production of unsymmetrical polyurea-urethane coated granular fertilizer products, and to the unsymmetrical polyurea-urethane coated granular fertilizer products produced by these processes. These processes comprise coating fertilizer granules with compounds which react to form unsymmetrical polyurea-urethane coatings, then the compounds are polymerized. Suitable compounds comprise a) an organic polyisocyanate component, and b) an alkanolamine component containing at least one primary or secondary amine group and at least one hydroxyl group. These compounds are present in sufficient quantities that the NCO to active hydrogen group is from about 0.5:1.0 up to about 1.5:1.0. It is necessary that sufficient amounts of these compounds are applied to the fertilizer granules such that the unsymmetrical polyurea-urethane coated granular fertilizer particles contain from about 0.5 to about 15% by weight of polyurea-urethane, based on the total weight of the encapsulated fertilizer particles.
Patent IL-131491-A0 (IL)
Title: Modular filtration systems and methods
IPC: B01D63/14
Filed: 1998-04-13
Abstract: A filtration system includes production modules (305) which are mechanically coupled in series, and which contain filters that are fluidly coupled in parallel. Among the many different possibilities contemplated, each production module may advantageously contain not only a filter (314), but also flowpaths for feed fluid (334a), waste fluid (334b), and product fluid (334c) so that a series of coupled modules can be installed, accessed, and removed as single unit. It is further contemplated that coupled modules may be deployed in space efficient manner, such as by insertion into a deep or shall well, a tower, along the ground, into the side of a hill or mountain, or even under a road or parking lot. It is still further contemplated that adjacent production modules may be designed to mate with one another using a slip fit joint, and that the production modules may be maintained in mating relationship through connections to supporting cables or rods.
Patent IL-131894-A0 (IL)
Title: Distortion resistant double-data correcting color ransition barcode and method ofgenerating and using same
IPC: G06K7/12
Filed: 1998-04-08
Abstract: A color barcode symbology is disclosed that can be accurately decoded despite severe distortions, misreads or altered symbols. This disclosed barcode is a color transition barcode having linear growth properties designed to resist the single or combined effects of: scaling distortions, perspective distortions, shear distortions, and wave distortions of both the uniform and non-uniform type distributed across the barcode's vertical or horizontal axis. This color barcode symbology is also resistant to missing symbols and altered symbols while offering, high security, error checking, and double error correcting capability.
Patent IL-135041-A0 (IL)
Title: X-ray absorbing material and variants
IPC: G21F3/00
Filed: 1998-09-24
Abstract: The present invention relates to an X-ray absorbing material which can be used in medicine as well as in the production of special protection clothes, protection screens, housings, protection coatings and isolation materials. In a first embodiment, the material uses as a filler a poly-dispersed kneading-segregated mixture containing metallic particles having a size of between 10<-9> and 10<-3> m, wherein said particles are bonded to the surface of a textile base. The density of the material is defined by the relation qN = (0.01 - 0.20)qP wherein qN is the density of the X-ray absorbing material as a whole while qP is the density of the material used for the particles of the X-ray absorbing filler. In a second embodiment, this invention uses as a filler the above-mentioned mixture though the particles are surrounded by the volume of a matrix made of a compound that solidifies under atmospheric pressure. The total mass of the poly-dispersed and segregated mixture is defined by the relation M = (0.05 - 0.5)m where M is the total mass of the X-ray absorbing poly-dispersed and segregated filler, while m is the equivalent mass of the filler material which is equal by its protection properties to the mass M. In a third embodiment, this invention uses as a filler the above-mentioned mixture though the particles we bonded to an intermediate substrate consisting of a textile base and surrounded by the volume of a matrix.
Patent IL-139258-A0 (IL)
Title: Stable carbanilide composition
IPC: A61K31/17
Filed: 1999-04-29
Abstract: A liquid composition comprising a) an anti-bacterial aromatic carbanilide b) a water soluble polyethylene glycol of molecular weight of at least about 200 the quantity of b sufficient to solubilize the said carbanilide, c) a fragrance useful in a personal cleansing composition in quantities sufficient to at least (1) prolong the solubilization of a in b or (2) inhibit the decomposition of the carbanilide or a mixture of (1) and (2).
Patent IL-141965-A0 (IL)
Title: Non-endogenous, constitutively activated human g protein-coupled receptors
IPC: G01N33/15
Filed: 1999-10-12
Abstract: Disclosed herein are constitutively activated, non-endogenous versions of endogenous human G protein-coupled receptors comprising (a) the following amino acid sequence region (C-terminus to N-terminus orientation) and/or (b) the following nucleic acid sequence region (3' to 5' orientation) transversing the transmembrane-6 (TM6) and intracellular loop-3 (IC3) regions of the GPCR: (a) P<SUP>1 </SUP>AA<SUB>15</SUB>X and/or (b) p<SUP>codon </SUP>(AA-codon)<SUB>15 </SUB>X<SUB>codon</SUB>, respectively. In a most preferred embodiment, P<SUP>1 </SUP>and P<SUP>codon </SUP>are endogenous proline and an endogenous nucleic acid encoding region encoding proline, respectively, located within TM6 of the non-endogenous GPCR; AA<SUB>15 </SUB>and (AA-codon)<SUB>15 </SUB>are 15 endogenous amino acid residues and 15 codons encoding endogenous amino acid residues, respectively; and X and X<SUB>codon </SUB>are non-endogenous lysine and a non-endogenous nucleic acid encoding region encoding lysine, respectively, located within IC3 of the non-endogenous GPCR. Because it is most preferred that the non-endogenous human GPCRs which incorporate these mutations are incorporated into mammalian cells and utilized for the screening of candidate compounds, the non-endogenous human GPCR incorporating the mutation need not be purified and isolated per se (i.e., these are incorporated within the cellular membrane of a mammalian cell), although such purified and isolated non-endogenous human GPCRs are well within the purview of this disclosure.
Patent IL-145838-A0 (IL)
Title: Methods of assessing, improving, urogenital health in postmenopausal women
IPC: A61P43/00
Filed: 2001-10-08
Abstract: This invention relates to methods and kits useful for improving or maintaining urogenital health using an estrogen agonist / antagonist. The methods of treatment are effective for improving or maintaining urogenital health while substantially reducing the concomitant liability of adverse effects associated with estrogen administration. This invention also relates to methods of assessing vaginal health.
Patent IL-154495-A0 (IL)
Title: Erbb4 antagonists
IPC: A61K38/00
Filed: 2001-08-29
Abstract: The present invention concerns methods and means for controlling excessive proliferation and/or migration of smooth muscle cells, and in particular for treating stenosis, by using antagonists of a native ErbB4 receptor. The invention further concerns a method for the identification of ErbB4 agonists and antagonists capable of inhibiting or enhancing the proliferation or migration of smooth muscle cells.
Patent IL-156708-A0 (IL)
Title: Microorganisms and process for enhanced production of pantothenate
IPC: C12P13/04
Filed: 2002-01-18
Abstract: The present invention features improved methods for the enhanced production of pantoate and pantothenate utilizing microorganisms having modified pantothenate biosynthetic enzyme activities and having modified methylenetetrahydrofolate (MTF) biosynthetic enzyme activities. In particular, the invention features methods for enhancing production of desired products by increasing levels of a key intermediate, ketopantoate by enzymes that contribute to its synthesis. Recombinant microorganisms and conditions for culturing same are also are featured. Also featured are compositions produced by such microorganisms.
Patent IL-172302-A0 (IL)
Title: Tube assembly
IPC: F16L/
Filed: 2005-12-01
Abstract: The tube formation (1) to accommodate cables consists of at least three inner tubes (2) for cables. The jacket tube (3) has an outside circumference which corresponds to standard circular tubes. The jacket tube is constructed gas and water tight and has at least an internal compressive strength of 0.5 bar. The jacket tube during assembly and transporting has a flat-to-oval form and at the outlet of the inner tubes the end of the jacket tube on both sides is deformable to a circular cross section (7), whereby the inner tubes are contained loosely therein and one on top of the other.
Patent IL-174579-A0 (IL)
Title: Additive for reducing paper linting and dusting
IPC: D21H17/10
Filed: 2006-03-27
Abstract: The present invention relates to a new paper making composition useful for reducing linting and dusting in paper, a method for reducing paper linting and dusting wherein certain phosphate esters are added to a fiber pulp during the paper making process and the novel additive composition for reducing linting and dusting in paper comprising the phosphate ester.
Patent RO-125902-A0 (RO)
Title: Biogas installation for individual rural farms
Inventor: MATEESCU CARMEN
IPC: C02F11/06
Filed: 2010-07-14
Abstract: The invention relates to a biogas installation which can be placed in an individual rural farm for treating organic waste of the animal dejection type, agricultural and gardening waste, food waste and the like and for exploiting the energetic potential thereof. According to the invention, the installation comprises a hemispheric digestion reactor (1) made of bricks and cement mortar, having a bottom of rigid construction with a slightly cambered surface, made of brick masonry with cement or concrete pavement and provided with some internal baffles of masonry for partially dividing and providing the internal circulation of the organic mass in a floating biogas reservoir (2) of cylindrical shape for gathering and storing the biogas, with truncated cone-shaped cover base, made of stainless steel sheet and provided with a metal guiding framework with three arms arranged under an angle of 120°, on whose axle there is fixed a biogas pipe, a biomass mixing reservoir (3) and a reservoir (4) for discharging the digested sludge, both of them made of concrete and placed on the same side of the digestion reactor (1), as well as two identical conduits (5), a supply conduit and a discharge conduit, respectively, made of PVC-type plastics.
Patent RO-131796-A0 (RO)
Title: Protective device for road-surface manhole covers
Inventor: GIURGIU NICU
IPC: E02D29/14
Filed: 2016-11-24
Abstract: The invention relates to a protective device for road-surface covers which are meant to cover manholes and to close water, sewage, electric power, fiber optics, telephone or Internet public networks manholes. According to the invention, the device comprises a supporting framework assembly (1) and a cover (2) between which there is a sealing device consisting of two identical pieces (3.1 and 3.2) or of a semicircular piece, having a polygon-shaped section (a), mounted on a horizontal supporting surface (b) provided for the cover (2) in the construction of the framework (1), or on top of the gasket between the framework and the cover, the two sealing pieces (3.1 and 3.2) being made by casting of various metals or reinforced composite materials with moulding properties.
Patent RO-134815-A0 (RO)
Title: Kit and method of use for the diagnosis of ragweed allergy
Inventor: PANAITESCU CARMEN
IPC: C07K16/16
Filed: 2020-09-30
Abstract: The invention relates to a kit and a method for using it for the diagnosis of ragweed pollen allergy. The claimed kit comprises 11 recombinant allergens, namely Amb a 1, 3, 4, 5, 6, 8, 9, 10, 11 and Amb a 12, expressed and purified in E-coli host systems and Sf9 insects cells, implemented in the ELISA technique. The claimed method consists in that the recombinant ragweed pollen allergens are attached to the surface of the wells of an ELISA plate in which the serum of the patient presumed to be allergic is tested compared to a non-allergic person, using a serum-free buffer solution in order to assess IgE reactivity by the appearance of the color measured with a spectrophotometer, displayed as optical density (OD), so that, by interpreting the results, the molecular allergenic profile of the patient and the possible cross-reactivity are identified for the purpose of allergological diagnosis.
Patent RO-135199-A0 (RO)
Title: Method for detecting and evaluating pulmonary insterstitial disease based on computerized analysis of ultrasound images (b-pulmonary lines)
Inventor: RUSU-BOTH ROXANA
IPC: G06T7/00
Filed: 2020-12-14
Abstract: The invention relates to a method for detecting and evaluating pulmonary interstitial disease based on computerized analysis of ultrasound images resulting from transthoracic ultrasonography, determining and evaluating pulmonary interstitial changes by detecting and quantifying B-pulmonary lines in a list of analysis indices and developping the necessary algorithms for the quantitative evaluation of the indices of analysis of the area of interest. According to the invention, the method comprises the following steps: application of a Gaussian filter to the ultrasound image, in order to eliminate/reduce possible noises, extraction of the initial area of interest, achieved by removing from the original image the first horizontal third, equalization of the histogram adapted to highlighting of white zones, reduction of the color palette to remove artifacts by transforming colors that are close to black into black and those that are close to white into white, binarization of the image using a threshold value calculated with the Otsu method, extraction of the area of interest for quantitative evaluation of B lines, the application of the morphological operations of "opening" and "closing", in which the "opening" is made by an erosion operation followed by an expansion operation, in order to eliminate the noises left after binarization which do not represent a line B, and the "closing", through an operation of expansion followed by an operation of erosion, used for removing the small holes in the B lines, followed by the determination of auxiliary constructions in the form of radii for the identification of the B lines, the evaluation of the thickness and the number of present B lines and the evaluation of the distance between the determined B lines.
Patent AP-2000001859-A0 (AP)
Title: Method for treating multiple sclerosis
Inventor: CHRISTENSEN SIEGFRIED BENJAMIN
IPC: C07D271/06
Filed: 1999-01-06
Abstract: A method for treating copd comprsing administering compounds of formula (i)where x4 is a 1-substituted cyclohexyl group.
Patent MC-200022-A1 (MC)
IPC: D21H27/26
Filed: 1999-09-21
Abstract: The invention concerns a method for treating paper strips for making paper to be impregnated with synthetic resins, comprising the following steps: inserting (3) in the paper (1) a resin-based mixture (A); consecutively to or simultaneously with the insertion (3) of mixture (A), treating (4) at least one surface of the paper strip (1) by applying a resin-based mixture (B); drying (5) the paper; treating (6) the surface of at least one of the surfaces of the paper strip (1) by applying a resin-based mixture (C); drying (5) the paper. After drying and optionally glazing (7), the resulting surface provides for high fidelity printing. The invention further concerns paper to be impregnated with synthetic resins obtained by said method. The invention is useful for high pressure and/or low pressure lamination of supports such as particle boards, woodfibre boards, plywood sheets or the like.
Patent IE-910524-A1 (IE)
Title: Therapeutic nucleosides
IPC: A61K31/70
Filed: 1991-02-15
Abstract: The present invention relates to 3 min -fluoro nucleoside analogues and their use in medical therapy, particularly for the treatment or prophylaxis of human immunodeficiency virus and hepatitis B virus infections, to methods for their preparation and to formulations containing them.